☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 90-0199783 | ||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||
1275 Market Street | San Francisco | California | 94103-1410 | ||||||||
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Class A common stock, $0.001 par value | DLB | The New York Stock Exchange |
Item 1. | ||||||||
Item 2. | ||||||||
Item 3. | ||||||||
Item 4. | ||||||||
Item 1. | ||||||||
Item 1A. | ||||||||
Item 2. | ||||||||
Item 6. | ||||||||
Abbreviation | Term | |||||||
AAC | Advanced Audio Coding | |||||||
AFS | Available-For-Sale (Securities) | |||||||
AOCI | Accumulated Other Comprehensive Income (Loss) | |||||||
API | Application Programming Interface | |||||||
APIC | Additional Paid In-Capital | |||||||
ASC | Accounting Standards Codification | |||||||
ASP | Average Selling Price | |||||||
ASU | Accounting Standards Update | |||||||
ATSC | Advanced Television Systems Committee | |||||||
AVC | Advanced Video Coding | |||||||
AVR | Audio/Video Receiver | |||||||
CE | Consumer Electronics | |||||||
CODM | Chief Operating Decision Maker | |||||||
COGS | Cost Of Goods Sold | |||||||
COSO | Committee Of Sponsoring Organizations (Of The Treadway Commission) | |||||||
DD | Dolby Digital® | |||||||
DD+ | Dolby Digital Plus™ | |||||||
DMA | Digital Media Adapter | |||||||
DTV | Digital Television | |||||||
DVB | Digital Video Broadcasting | |||||||
DVD | Digital Versatile Disc | |||||||
EPS | Earnings Per Share | |||||||
ESP | Estimated Selling Price | |||||||
ESPP | Employee Stock Purchase Plan | |||||||
FASB | Financial Accounting Standards Board | |||||||
FCPA | Foreign Corrupt Practices Act | |||||||
G&A | General and Administrative | |||||||
HD | High Definition | |||||||
HDR | High-Dynamic Range | |||||||
HDTV | High Definition Television | |||||||
HE-AAC | High Efficiency Advanced Audio Coding | |||||||
HEVC | High Efficiency Video Coding | |||||||
HTIB | Home Theater In-A-Box | |||||||
IC | Integrated Circuit | |||||||
IMB | Integrated Media Block | |||||||
IBR | Incremental Borrowing Rate | |||||||
IP | Intellectual Property | |||||||
LP | Limited Partner/Partnership | |||||||
NOL | Net Operating Loss | |||||||
OECD | Organization For Economic Co-Operation & Development | |||||||
OEM | Original Equipment Manufacturer | |||||||
OTT | Over-The-Top | |||||||
PC | Personal Computer | |||||||
PCS | Post-Contract Support | |||||||
PP&E | Property, Plant, and Equipment | |||||||
PSO | Performance-Based Stock Option | |||||||
PSU | Performance-Based Restricted Stock Unit | |||||||
R&D | Research and Development | |||||||
ROU | Right-Of-Use | |||||||
RSU | Restricted Stock Unit | |||||||
S&M | Sales and Marketing | |||||||
SEC | U.S. Securities and Exchange Commission | |||||||
SERP | Supplemental Executive Retirement Plan | |||||||
STB | Set-Top Box | |||||||
TSR | Total Stockholder Return | |||||||
UHD | Ultra-High Definition | |||||||
U.S. GAAP | Generally Accepted Accounting Principles In The United States | |||||||
July 1, 2022 | September 24, 2021 | |||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 858,905 | $ | 1,225,380 | ||||
Restricted cash | 8,352 | 7,652 | ||||||
Short-term investments | 156,812 | 38,839 | ||||||
Accounts receivable, net of allowance for credit losses of $9,572 and $8,744 | 236,229 | 232,609 | ||||||
Contract assets, net of allowance for credit losses of $123 and $208 | 170,402 | 182,316 | ||||||
Inventories, net | 24,096 | 10,965 | ||||||
Prepaid expenses and other current assets | 49,923 | 62,737 | ||||||
Total current assets | 1,504,719 | 1,760,498 | ||||||
Long-term investments | 106,726 | 62,819 | ||||||
Property, plant and equipment, net | 517,870 | 534,381 | ||||||
Operating lease right-of-use assets | 53,702 | 67,128 | ||||||
Intangible assets, net | 119,251 | 122,890 | ||||||
Goodwill | 368,282 | 340,694 | ||||||
Deferred taxes | 183,545 | 156,020 | ||||||
Other non-current assets | 65,841 | 61,257 | ||||||
Total assets | $ | 2,919,936 | $ | 3,105,687 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 16,821 | $ | 17,779 | ||||
Accrued liabilities | 229,267 | 262,728 | ||||||
Income taxes payable | 3,850 | 1,334 | ||||||
Contract liabilities | 21,216 | 18,473 | ||||||
Operating lease liabilities | 14,331 | 15,403 | ||||||
Total current liabilities | 285,485 | 315,717 | ||||||
Non-current contract liabilities | 24,350 | 23,713 | ||||||
Non-current operating lease liabilities | 44,257 | 56,715 | ||||||
Other non-current liabilities | 106,319 | 105,310 | ||||||
Total liabilities | 460,411 | 501,455 | ||||||
Stockholders’ equity: | ||||||||
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 62,578,760 shares issued and outstanding at July 1, 2022 and 64,986,316 at September 24, 2021 | 57 | 59 | ||||||
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,086,629 shares issued and outstanding at July 1, 2022 and 36,086,779 at September 24, 2021 | 41 | 41 | ||||||
Retained earnings | 2,484,689 | 2,607,909 | ||||||
Accumulated other comprehensive loss | (30,426) | (10,030) | ||||||
Total stockholders’ equity – Dolby Laboratories, Inc. | 2,454,361 | 2,597,979 | ||||||
Controlling interest | 5,164 | 6,253 | ||||||
Total stockholders’ equity | 2,459,525 | 2,604,232 | ||||||
Total liabilities and stockholders’ equity | $ | 2,919,936 | $ | 3,105,687 |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||
July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | ||||||||||||||
Revenue: | |||||||||||||||||
Licensing | $ | 269,289 | $ | 271,569 | $ | 915,406 | $ | 948,159 | |||||||||
Products and services | 20,296 | 15,230 | 60,183 | 48,072 | |||||||||||||
Total revenue | 289,585 | 286,799 | 975,589 | 996,231 | |||||||||||||
Cost of revenue: | |||||||||||||||||
Cost of licensing | 13,756 | 12,480 | 45,363 | 41,486 | |||||||||||||
Cost of products and services | 22,201 | 19,164 | 58,818 | 57,840 | |||||||||||||
Total cost of revenue | 35,957 | 31,644 | 104,181 | 99,326 | |||||||||||||
Gross margin | 253,628 | 255,155 | 871,408 | 896,905 | |||||||||||||
Operating expenses: | |||||||||||||||||
Research and development | 62,859 | 62,094 | 199,104 | 191,674 | |||||||||||||
Sales and marketing | 87,114 | 80,714 | 268,514 | 234,205 | |||||||||||||
General and administrative | 57,113 | 56,116 | 218,250 | 169,968 | |||||||||||||
Gain on sale of assets | — | — | — | (13,871) | |||||||||||||
Restructuring charges | 976 | 140 | 6,043 | 10,904 | |||||||||||||
Total operating expenses | 208,062 | 199,064 | 691,911 | 592,880 | |||||||||||||
Operating income | 45,566 | 56,091 | 179,497 | 304,025 | |||||||||||||
Other income/(expense): | |||||||||||||||||
Interest income | 1,416 | 741 | 3,230 | 2,677 | |||||||||||||
Interest expense | (84) | (108) | (255) | (360) | |||||||||||||
Other income, net | 2,514 | 2,401 | 1,833 | 5,112 | |||||||||||||
Total other income | 3,846 | 3,034 | 4,808 | 7,429 | |||||||||||||
Income before income taxes | 49,412 | 59,125 | 184,305 | 311,454 | |||||||||||||
Provision for income taxes | (9,802) | (4,565) | (28,166) | (37,859) | |||||||||||||
Net income including controlling interest | 39,610 | 54,560 | 156,139 | 273,595 | |||||||||||||
Less: net (income)/loss attributable to controlling interest | (13) | 61 | 192 | (7,559) | |||||||||||||
Net income attributable to Dolby Laboratories, Inc. | $ | 39,597 | $ | 54,621 | $ | 156,331 | $ | 266,036 | |||||||||
Net income per share: | |||||||||||||||||
Basic | $ | 0.40 | $ | 0.54 | $ | 1.55 | $ | 2.63 | |||||||||
Diluted | $ | 0.39 | $ | 0.52 | $ | 1.52 | $ | 2.54 | |||||||||
Weighted-average shares outstanding: | |||||||||||||||||
Basic | 100,213 | 101,351 | 100,936 | 101,177 | |||||||||||||
Diluted | 101,474 | 104,633 | 102,993 | 104,607 | |||||||||||||
Related party rent expense: | |||||||||||||||||
Included in operating expenses | $ | — | $ | (5) | $ | — | $ | (392) | |||||||||
Included in net income attributable to controlling interest | $ | 71 | $ | 71 | $ | 213 | $ | 311 | |||||||||
Cash dividend declared per common share | $ | 0.25 | $ | 0.22 | $ | 0.75 | $ | 0.66 | |||||||||
Cash dividend paid per common share | $ | 0.25 | $ | 0.22 | $ | 0.75 | $ | 0.66 |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||
July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | ||||||||||||||
Net income including controlling interest | $ | 39,610 | $ | 54,560 | $ | 156,139 | $ | 273,595 | |||||||||
Other comprehensive income/(loss): | |||||||||||||||||
Currency translation adjustments gains/(losses), net of tax expense of $0, ($110), $0, and ($617) | (14,086) | 898 | (15,842) | 8,300 | |||||||||||||
Unrealized losses on investments, net of tax benefit/(expense) of $3, $42, ($2), and $88 | (426) | (162) | (4,446) | (522) | |||||||||||||
Unrealized losses on cash flow hedges, net of tax benefit/(expense) of $178, ($123), $98, and ($453) | (498) | (1,658) | (320) | (1,876) | |||||||||||||
Total other comprehensive income/(loss), net of tax | (15,010) | (922) | (20,608) | 5,902 | |||||||||||||
Total comprehensive income | 24,600 | 53,638 | 135,531 | 279,497 | |||||||||||||
Less: comprehensive (income)/loss attributable to controlling interest | 252 | (10) | 404 | (7,899) | |||||||||||||
Comprehensive income attributable to Dolby Laboratories, Inc. | $ | 24,852 | $ | 53,628 | $ | 135,935 | $ | 271,598 |
Fiscal Quarter Ended | |||||||||||||||||||||||
Dolby Laboratories, Inc. | |||||||||||||||||||||||
Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Total Stockholders' Equity - Dolby Laboratories, Inc. | Controlling Interest | Total Stockholders' Equity | |||||||||||||||||
Balance at April 1, 2022 | $ | 99 | $ | — | $ | 2,615,354 | $ | (15,681) | $ | 2,599,772 | $ | 5,416 | $ | 2,605,188 | |||||||||
Net income | — | 39,597 | — | 39,597 | 13 | 39,610 | |||||||||||||||||
Other comprehensive loss, net of tax | — | — | — | (14,745) | (14,745) | (265) | (15,010) | ||||||||||||||||
Stock-based compensation expense | — | 27,608 | — | — | 27,608 | — | 27,608 | ||||||||||||||||
Repurchase of common stock | (2) | (44,871) | (145,127) | — | (190,000) | — | (190,000) | ||||||||||||||||
Cash dividends declared and paid on common stock | — | — | (25,135) | — | (25,135) | — | (25,135) | ||||||||||||||||
Common stock issued under employee stock plans | 1 | 18,537 | — | — | 18,538 | — | 18,538 | ||||||||||||||||
Tax withholdings on vesting of restricted stock | — | (1,274) | — | — | (1,274) | — | (1,274) | ||||||||||||||||
Balance at July 1, 2022 | $ | 98 | $ | — | $ | 2,484,689 | $ | (30,426) | $ | 2,454,361 | $ | 5,164 | $ | 2,459,525 |
Fiscal Year-To-Date Ended | |||||||||||||||||||||||
Dolby Laboratories, Inc. | |||||||||||||||||||||||
Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Total Stockholders' Equity - Dolby Laboratories, Inc. | Controlling Interest | Total Stockholders' Equity | |||||||||||||||||
Balance at September 24, 2021 | $ | 100 | $ | — | $ | 2,607,909 | $ | (10,030) | $ | 2,597,979 | $ | 6,253 | $ | 2,604,232 | |||||||||
Net income | — | — | 156,331 | — | 156,331 | (192) | 156,139 | ||||||||||||||||
Other comprehensive loss, net of tax | — | — | — | (20,396) | (20,396) | (212) | (20,608) | ||||||||||||||||
Distributions to controlling interest | — | — | — | — | — | (1,435) | (1,435) | ||||||||||||||||
Stock-based compensation expense | — | 87,963 | — | — | 87,963 | — | 87,963 | ||||||||||||||||
Repurchase of common stock | (4) | (107,567) | (202,915) | — | (310,486) | — | (310,486) | ||||||||||||||||
Cash dividends declared and paid on common stock | — | — | (75,816) | — | (75,816) | — | (75,816) | ||||||||||||||||
Common stock issued under employee stock plans | 2 | 53,598 | — | — | 53,600 | — | 53,600 | ||||||||||||||||
Tax withholdings on vesting of restricted stock | — | (33,994) | — | — | (33,994) | — | (33,994) | ||||||||||||||||
Deconsolidation of subsidiary | — | — | (820) | — | (820) | 750 | (70) | ||||||||||||||||
Balance at July 1, 2022 | $ | 98 | $ | — | $ | 2,484,689 | $ | (30,426) | $ | 2,454,361 | $ | 5,164 | $ | 2,459,525 |
Fiscal Quarter Ended | |||||||||||||||||||||||
Dolby Laboratories, Inc. | |||||||||||||||||||||||
Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Loss | Total Stockholders' Equity - Dolby Laboratories, Inc. | Controlling Interest | Total Stockholders' Equity | |||||||||||||||||
Balance at March 26, 2021 | $ | 100 | $ | — | $ | 2,591,870 | $ | (4,039) | $ | 2,587,931 | $ | 6,289 | $ | 2,594,220 | |||||||||
Net income | — | — | 54,621 | — | 54,621 | (61) | 54,560 | ||||||||||||||||
Other comprehensive income/(loss), net of tax | — | — | — | (993) | (993) | 71 | (922) | ||||||||||||||||
Stock-based compensation expense | — | 24,836 | — | — | 24,836 | — | 24,836 | ||||||||||||||||
Repurchase of common stock | (1) | (41,253) | 2,265 | — | (38,989) | — | (38,989) | ||||||||||||||||
Cash dividends declared and paid on common stock | — | — | (22,309) | — | (22,309) | — | (22,309) | ||||||||||||||||
Common stock issued under employee stock plans | 1 | 17,990 | — | — | 17,991 | — | 17,991 | ||||||||||||||||
Tax withholdings on vesting of restricted stock | — | (1,573) | — | — | (1,573) | — | (1,573) | ||||||||||||||||
Balance at June 25, 2021 | $ | 100 | $ | — | $ | 2,626,447 | $ | (5,032) | $ | 2,621,515 | $ | 6,299 | $ | 2,627,814 |
Fiscal Year-To-Date Ended | |||||||||||||||||||||||
Dolby Laboratories, Inc. | |||||||||||||||||||||||
Common Stock | Additional Paid-In Capital | Retained Earnings | Accumulated Other Comprehensive Income/(Loss) | Total Stockholders' Equity - Dolby Laboratories, Inc. | Controlling Interest | Total Stockholders' Equity | |||||||||||||||||
Balance at September 25, 2020 | $ | 99 | $ | — | $ | 2,443,138 | $ | (10,594) | $ | 2,432,643 | $ | 5,762 | $ | 2,438,405 | |||||||||
Net income | — | — | 266,036 | — | 266,036 | 7,559 | 273,595 | ||||||||||||||||
Other comprehensive income, net of tax | — | — | — | 5,562 | 5,562 | 340 | 5,902 | ||||||||||||||||
Distributions to controlling interest | — | — | — | — | — | (7,362) | (7,362) | ||||||||||||||||
Stock-based compensation expense | — | 75,562 | — | — | 75,562 | — | 75,562 | ||||||||||||||||
Repurchase of common stock | (2) | (133,918) | (15,844) | — | (149,764) | — | (149,764) | ||||||||||||||||
Cash dividends declared and paid on common stock | — | — | (66,883) | — | (66,883) | — | (66,883) | ||||||||||||||||
Common stock issued under employee stock plans | 3 | 89,145 | — | — | 89,148 | — | 89,148 | ||||||||||||||||
Tax withholdings on vesting of restricted stock | — | (30,789) | — | — | (30,789) | — | (30,789) | ||||||||||||||||
Balance at June 25, 2021 | $ | 100 | $ | — | $ | 2,626,447 | $ | (5,032) | $ | 2,621,515 | $ | 6,299 | $ | 2,627,814 |
Fiscal Year-To-Date Ended | ||||||||
July 1, 2022 | June 25, 2021 | |||||||
Operating activities: | ||||||||
Net income including controlling interest | $ | 156,139 | $ | 273,595 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 69,382 | 70,701 | ||||||
Stock-based compensation | 87,963 | 75,562 | ||||||
Amortization of operating lease right-of-use assets | 11,658 | 12,744 | ||||||
Amortization of premium on investments | 1,109 | 1,051 | ||||||
Provision for/(benefit from) credit losses | 2,166 | (567) | ||||||
Deferred income taxes | (29,143) | (26,479) | ||||||
Gain on sale of assets | — | (13,871) | ||||||
Other non-cash items affecting net income | (2,388) | (3,293) | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | (5,395) | (93,848) | ||||||
Contract assets, net | 11,999 | (5,402) | ||||||
Inventories | (12,231) | 14,828 | ||||||
Operating lease right-of-use assets | (941) | (4,982) | ||||||
Prepaid expenses and other assets | (1,169) | 15,468 | ||||||
Accounts payable and accrued liabilities | (29,782) | 31,788 | ||||||
Income taxes, net | 17,023 | 4,293 | ||||||
Contract liabilities | 3,314 | 512 | ||||||
Operating lease liabilities | (10,539) | (7,507) | ||||||
Other non-current liabilities | (1,898) | (6,613) | ||||||
Net cash provided by operating activities | 267,267 | 337,980 | ||||||
Investing activities: | ||||||||
Purchases of marketable securities | (248,156) | (48,066) | ||||||
Proceeds from sales of marketable securities | 8,970 | 7,332 | ||||||
Proceeds from maturities of marketable securities | 75,890 | 37,040 | ||||||
Purchases of property, plant, and equipment | (37,218) | (42,619) | ||||||
Proceeds from sale of assets | — | 16,365 | ||||||
Payments for business combinations, net of cash acquired | (38,171) | — | ||||||
Purchases of intangible assets | (11,528) | — | ||||||
Purchases of other investments | (5,000) | — | ||||||
Net cash used in investing activities | (255,213) | (29,948) | ||||||
Financing activities: | ||||||||
Proceeds from issuance of common stock | 53,600 | 89,148 | ||||||
Repurchase of common stock | (310,486) | (149,764) | ||||||
Payment of cash dividend | (75,816) | (66,883) | ||||||
Distribution to controlling interest | (1,435) | (7,362) | ||||||
Shares repurchased for tax withholdings on vesting of restricted stock | (33,994) | (30,789) | ||||||
Net cash used in financing activities | (368,131) | (165,650) | ||||||
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash | (9,698) | 4,891 | ||||||
Net increase/(decrease) in cash, cash equivalents, and restricted cash | (365,775) | 147,273 | ||||||
Cash, cash equivalents, and restricted cash at beginning of period | 1,233,032 | 1,079,979 | ||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 867,257 | $ | 1,227,252 | ||||
Supplemental disclosure: | ||||||||
Cash paid for income taxes, net of refunds received | $ | 30,014 | $ | 45,713 | ||||
Non-cash investing activities and financing activities: | ||||||||
Change in property, plant, and equipment purchased, unpaid at period-end | $ | (2,897) | $ | 1,230 | ||||
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||||||||||||||||||||
Revenue | July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | |||||||||||||||||||||||||||||||
Licensing | $ | 269,289 | 93 | % | $ | 271,569 | 95 | % | $ | 915,406 | 94 | % | $ | 948,159 | 95 | % | |||||||||||||||||||
Products and services | 20,296 | 7 | % | 15,230 | 5 | % | 60,183 | 6 | % | 48,072 | 5 | % | |||||||||||||||||||||||
Total revenue | $ | 289,585 | 100 | % | $ | 286,799 | 100 | % | $ | 975,589 | 100 | % | $ | 996,231 | 100 | % |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||||||||||||||||||||
Market | July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | |||||||||||||||||||||||||||||||
Broadcast | $ | 99,327 | 37 | % | $ | 123,955 | 46 | % | $ | 325,441 | 36 | % | $ | 368,068 | 39 | % | |||||||||||||||||||
Mobile | 63,237 | 23 | % | 49,861 | 18 | % | 204,212 | 22 | % | 221,157 | 23 | % | |||||||||||||||||||||||
CE | 38,663 | 14 | % | 37,805 | 14 | % | 150,192 | 16 | % | 138,010 | 15 | % | |||||||||||||||||||||||
PC | 26,947 | 10 | % | 24,870 | 9 | % | 119,190 | 13 | % | 108,709 | 11 | % | |||||||||||||||||||||||
Other | 41,115 | 16 | % | 35,078 | 13 | % | 116,371 | 13 | % | 112,215 | 12 | % | |||||||||||||||||||||||
Total licensing revenue | $ | 269,289 | 100 | % | $ | 271,569 | 100 | % | $ | 915,406 | 100 | % | $ | 948,159 | 100 | % |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||||||||||||||||||||
Revenue By Geographic Location | July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | |||||||||||||||||||||||||||||||
United States | $ | 78,471 | 27 | % | $ | 73,355 | 26 | % | $ | 375,680 | 39 | % | $ | 327,696 | 33 | % | |||||||||||||||||||
International | 211,114 | 73 | % | 213,444 | 74 | % | 599,909 | 61 | % | 668,535 | 67 | % | |||||||||||||||||||||||
Total revenue | $ | 289,585 | 100 | % | $ | 286,799 | 100 | % | $ | 975,589 | 100 | % | $ | 996,231 | 100 | % |
July 1, 2022 | September 24, 2021 | Change ($) | Change (%) | |||||||||||
Accounts receivable, net | $ | 236,229 | $ | 232,609 | $ | 3,620 | 2 | % | ||||||
Contract assets, net | 170,402 | 182,316 | (11,914) | (7) | % | |||||||||
Contract liabilities - current | 21,216 | 18,473 | 2,743 | 15 | % | |||||||||
Contract liabilities - non-current | 24,350 | 23,713 | 637 | 3 | % | |||||||||
July 1, 2022 | September 24, 2021 | ||||||||||
Trade accounts receivable | $ | 148,665 | $ | 160,112 | |||||||
Accounts receivable from patent administration program licensees | 97,136 | 81,241 | |||||||||
Contract assets | 170,525 | 182,524 | |||||||||
Accounts receivable, gross and contract assets, gross | 416,326 | 423,877 | |||||||||
Less: allowance for credit losses on accounts receivable and contract assets | (9,695) | (8,952) | |||||||||
Total accounts receivable and contract assets, net | $ | 406,631 | $ | 414,925 |
Allowance for Credit Losses | Beginning Balance | Charges/(Credits) to S&M and G&A | Additions/(Deductions) | Ending Balance | ||||||||||
For fiscal year-to-date period ended: | ||||||||||||||
September 24, 2021 | $ | 15,908 | $ | (2,889) | $ | (4,067) | $ | 8,952 | ||||||
July 1, 2022 | 8,952 | 2,166 | (852) | 10,266 | ||||||||||
July 1, 2022 | September 24, 2021 | ||||||||||
Raw materials | $ | 12,685 | $ | 2,792 | |||||||
Work in process | 4,697 | 3,461 | |||||||||
Finished goods | 6,714 | 4,712 | |||||||||
Total inventories | $ | 24,096 | $ | 10,965 |
July 1, 2022 | September 24, 2021 | ||||||||||
Prepaid expenses | $ | 28,438 | $ | 29,964 | |||||||
Other current assets | 21,485 | 32,773 | |||||||||
Total prepaid expenses and other current assets | $ | 49,923 | $ | 62,737 |
July 1, 2022 | September 24, 2021 | ||||||||||
Amounts payable to patent administration program partners | $ | 77,465 | $ | 72,847 | |||||||
Accrued compensation and benefits | 73,518 | 107,322 | |||||||||
Accrued professional fees | 11,802 | 11,737 | |||||||||
Unpaid property, plant, and equipment additions | 16,313 | 17,839 | |||||||||
Accrued customer refunds | 4,902 | 14,151 | |||||||||
Accrued market development funds | 7,728 | 7,777 | |||||||||
Other accrued liabilities | 37,539 | 31,055 | |||||||||
Total accrued liabilities | $ | 229,267 | $ | 262,728 |
July 1, 2022 | September 24, 2021 | ||||||||||
Supplemental retirement plan obligations | $ | 4,266 | $ | 4,877 | |||||||
Non-current tax liabilities (1) | 88,801 | 85,063 | |||||||||
Other liabilities | 13,252 | 15,370 | |||||||||
Total other non-current liabilities | $ | 106,319 | $ | 105,310 |
July 1, 2022 | September 24, 2021 | ||||||||||||||||||||||
Less Than 12 Months | 12 Months Or Greater | Less Than 12 Months | |||||||||||||||||||||
Investment Type | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | |||||||||||||||||
Certificate of deposit | $ | 13,367 | $ | (32) | $ | — | $ | — | $ | 600 | $ | — | |||||||||||
U.S. agency securities | 15,479 | (29) | 536 | (20) | 1,449 | (2) | |||||||||||||||||
Government bonds | 72,788 | (1,926) | 3,300 | (122) | 8,940 | (16) | |||||||||||||||||
Commercial paper | 17,580 | (31) | — | — | — | — | |||||||||||||||||
Corporate bonds | 79,201 | (1,440) | 7,788 | (206) | 22,964 | (25) | |||||||||||||||||
Municipal debt securities | 37,949 | (420) | 476 | (24) | 7,031 | (9) | |||||||||||||||||
Total | $ | 236,364 | $ | (3,878) | $ | 12,100 | $ | (372) | $ | 40,984 | $ | (52) |
July 1, 2022 | September 24, 2021 | ||||||||||||||||
Range of maturity | Amortized Cost | Fair Value | Amortized Cost | Fair Value | |||||||||||||
Due within 1 year | $ | 270,446 | $ | 269,123 | $ | 273,884 | $ | 274,037 | |||||||||
Due in 1 to 2 years | 61,673 | 60,081 | 40,739 | 40,874 | |||||||||||||
Due in 2 to 5 years | 38,911 | 37,652 | 15,506 | 15,490 | |||||||||||||
Total | $ | 371,030 | $ | 366,856 | $ | 330,129 | $ | 330,401 |
Property, Plant, and Equipment | July 1, 2022 | September 24, 2021 | |||||||||
Land | $ | 41,897 | $ | 42,041 | |||||||
Buildings and building improvements | 286,104 | 284,146 | |||||||||
Leasehold improvements | 87,051 | 88,549 | |||||||||
Machinery and equipment | 136,763 | 128,008 | |||||||||
Computer equipment and software | 268,286 | 258,981 | |||||||||
Furniture and fixtures | 33,647 | 33,565 | |||||||||
Equipment provided under operating leases | 229,424 | 214,109 | |||||||||
Construction-in-progress | 18,193 | 22,923 | |||||||||
Property, plant, and equipment, gross | 1,101,365 | 1,072,322 | |||||||||
Less: accumulated depreciation | (583,495) | (537,941) | |||||||||
Property, plant, and equipment, net | $ | 517,870 | $ | 534,381 |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||||||||
July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | ||||||||||||||||||||
Lease cost | |||||||||||||||||||||||
Operating lease cost | $ | 4,177 | $ | 4,801 | $ | 13,335 | $ | 14,548 | |||||||||||||||
Variable lease cost | 379 | 242 | 1,218 | 475 | |||||||||||||||||||
Total lease cost | $ | 4,556 | $ | 5,043 | $ | 14,553 | $ | 15,023 |
Fiscal Year-To Date Ended | |||||||||||
July 1, 2022 | June 25, 2021 | ||||||||||
Other information | |||||||||||
Cash paid for amounts included in the measurement of operating lease liabilities | $ | 13,147 | $ | 14,366 | |||||||
Right-of-use assets obtained in exchange for operating lease obligations | 1,459 | 5,013 |
July 1, 2022 | September 24, 2021 | ||||||||||
Operating Leases | |||||||||||
Weighted-average remaining lease term | 5.5 years | 5.8 years | |||||||||
Weighted-average discount rate | 3.1 | % | 3.1 | % |
July 1, 2022 | |||||
Operating Leases | |||||
Remainder of Fiscal 2022 | $ | 4,266 | |||
Fiscal 2023 | 15,549 | ||||
Fiscal 2024 | 13,122 | ||||
Fiscal 2025 | 9,331 | ||||
Fiscal 2026 | 5,778 | ||||
Thereafter | 16,378 | ||||
Total undiscounted lease payments | 64,424 | ||||
Less: imputed interest | (5,836) | ||||
Total lease liabilities | $ | 58,588 |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||||||||
July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | ||||||||||||||||||||
Operating Lease Income | |||||||||||||||||||||||
Variable operating lease income | $ | 10.7 | $ | 2.7 | $ | 25.2 | $ | 3.5 | |||||||||||||||
Fixed operating lease income | 0.7 | 1.0 | 2.3 | 3.2 |
July 1, 2022 | |||||||||||
Operating Leases | Sales-Type Leases | ||||||||||
Remainder of Fiscal 2022 | $ | 26 | $ | 1,595 | |||||||
Fiscal 2023 | 774 | 1,595 | |||||||||
Fiscal 2024 | 794 | 795 | |||||||||
Fiscal 2025 | 815 | 395 | |||||||||
Fiscal 2026 | 732 | 395 | |||||||||
Thereafter | — | — | |||||||||
Total undiscounted cash flows | $ | 3,141 | 4,775 | ||||||||
Less: present value of lease payments (recognized as lease receivables) | (4,333) | ||||||||||
Difference | $ | 442 |
Goodwill | |||||
Balance at September 24, 2021 | $ | 340,694 | |||
Acquired goodwill (1) | 31,638 | ||||
Translation adjustments | (4,050) | ||||
Balance at July 1, 2022 | $ | 368,282 |
July 1, 2022 | September 24, 2021 | ||||||||||||||||||||||
Intangible Assets | Cost | Accumulated Amortization | Net | Cost | Accumulated Amortization | Net | |||||||||||||||||
Acquired patents and technology | $ | 361,497 | $ | (252,896) | $ | 108,601 | $ | 343,280 | $ | (233,789) | $ | 109,491 | |||||||||||
Customer relationships | 66,178 | (55,717) | 10,461 | 65,822 | (52,730) | 13,092 | |||||||||||||||||
Other intangible assets | 23,012 | (22,823) | 189 | 22,972 | (22,665) | 307 | |||||||||||||||||
Total | $ | 450,687 | $ | (331,436) | $ | 119,251 | $ | 432,074 | $ | (309,184) | $ | 122,890 |
Fiscal Year | Amortization Expense | ||||
Remainder of 2022 | $ | 7,045 | |||
2023 | 26,083 | ||||
2024 | 23,954 | ||||
2025 | 8,884 | ||||
2026 | 7,993 | ||||
Thereafter | 45,292 | ||||
Total | $ | 119,251 |
Grant Date | Aggregate Shares Granted at Target Award | Aggregate Shares Exercisable at Vest Date (1) | Percentage Vested of Target Award | Vested Date | ||||||||||
December 15, 2015 | 419,623 | 334,623 | 125 | % | December 2018 | |||||||||
December 15, 2016 | 276,199 | 240,539 | 95 | % | December 2019 | |||||||||
December 15, 2017 | 264,000 | 253,440 | 96 | % | December 2020 | |||||||||
December 15, 2018 | 241,100 | 158,700 | 75 | % | December 2021 |
Shares | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Life | Aggregate Intrinsic Value (1) | |||||||||||
(in thousands) | (in years) | (in thousands) | ||||||||||||
Options outstanding at September 25, 2021 | 4,577 | $ | 59.18 | |||||||||||
Grants | 369 | 88.37 | ||||||||||||
Exercises | (685) | 52.97 | ||||||||||||
Forfeitures and cancellations | (121) | 73.58 | ||||||||||||
Options outstanding at July 1, 2022 | 4,140 | 62.38 | 5.62 | $ | 47,767 | |||||||||
Options vested and expected to vest at July 1, 2022 | 3,974 | 61.82 | 5.54 | 47,724 | ||||||||||
Options exercisable at July 1, 2022 | 3,033 | 56.26 | 4.68 | 46,015 |
Shares | Weighted-Average Grant Date Fair Value | |||||||
(in thousands) | ||||||||
Non-vested at September 24, 2021 | 3,335 | $ | 77.46 | |||||
Granted | 1,673 | 86.93 | ||||||
Vested | (1,107) | 71.80 | ||||||
Forfeitures | (291) | 80.27 | ||||||
Non-vested at July 1, 2022 | 3,610 | $ | 83.36 |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | |||||||||||||
July 1, 2022 | July 1, 2022 | June 25, 2021 | ||||||||||||
Expected term (in years) | 4.78 | 4.78 | 4.88 | |||||||||||
Risk-free interest rate | 3.0 | % | 1.5 | % | 0.4 | % | ||||||||
Expected stock price volatility | 29.7 | % | 28.8 | % | 28.7 | % | ||||||||
Dividend yield | 1.3 | % | 1.1 | % | 1.1 | % |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||
July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | ||||||||||||||
Compensation expense | |||||||||||||||||
Stock options | $ | 2,321 | $ | 3,203 | $ | 7,939 | $ | 10,913 | |||||||||
Restricted stock units (1) | 23,715 | 20,348 | 75,121 | 60,594 | |||||||||||||
Employee stock purchase plan | 1,572 | 1,285 | 4,903 | 4,055 | |||||||||||||
Total stock-based compensation | 27,608 | 24,836 | 87,963 | 75,562 | |||||||||||||
Estimated benefit from income taxes | (4,280) | (3,944) | (13,811) | (12,015) | |||||||||||||
Total stock-based compensation, net of tax | $ | 23,328 | $ | 20,892 | $ | 74,152 | $ | 63,547 |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||
July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | ||||||||||||||
Compensation expense | |||||||||||||||||
Cost of products and services | $ | 415 | $ | 426 | $ | 1,407 | $ | 1,549 | |||||||||
Research and development | 9,171 | 7,296 | 28,428 | 22,419 | |||||||||||||
Sales and marketing | 9,718 | 9,286 | 31,757 | 28,192 | |||||||||||||
General and administrative | 8,304 | 7,828 | 26,371 | 23,402 | |||||||||||||
Total stock-based compensation expense | 27,608 | 24,836 | 87,963 | 75,562 | |||||||||||||
Estimated benefit from income taxes | (4,280) | (3,944) | (13,811) | (12,015) | |||||||||||||
Total stock-based compensation, net of tax | $ | 23,328 | $ | 20,892 | $ | 74,152 | $ | 63,547 |
Authorization Period | Authorization Amount | ||||
Fiscal 2010: November 2009 | $ | 250,000 | |||
Fiscal 2010: July 2010 | 300,000 | ||||
Fiscal 2011: July 2011 | 250,000 | ||||
Fiscal 2012: February 2012 | 100,000 | ||||
Fiscal 2015: October 2014 | 200,000 | ||||
Fiscal 2017: January 2017 | 200,000 | ||||
Fiscal 2018: July 2018 | 350,000 | ||||
Fiscal 2019: July 2019 | 350,000 | ||||
Fiscal 2021: July 2021 | 350,000 | ||||
Fiscal 2022: February 2022 | 250,000 | ||||
Total | $ | 2,600,000 |
Quarterly Repurchase Activity | Shares Repurchased | Cost (1) | Average Price Paid Per Share (2) | ||||||||
(in thousands) | |||||||||||
Q1 - Quarter ended December 31, 2021 | 408,508 | $ | 35,573 | $ | 87.08 | ||||||
Q2 - Quarter ended April 1, 2022 | 1,116,032 | 84,913 | 76.08 | ||||||||
Q3 - Quarter ended July 1, 2022 | 2,549,474 | 190,000 | 74.53 | ||||||||
Total | 4,074,014 | $ | 310,486 |
Fiscal Period | Announcement Date | Record Date | Payment Date | Cash Dividend Per Common Share | Dividend Payment | |||||||||||||||
Q1 - Quarter ended December 31, 2021 | February 3, 2022 | February 16, 2022 | February 23, 2022 | $ | 0.25 | $25.3 million | ||||||||||||||
Q2 - Quarter ended April 1, 2022 | May 5, 2022 | May 17, 2022 | May 25, 2022 | $ | 0.25 | $25.1 million | ||||||||||||||
Q3 - Quarter ended July 1, 2022 | August 9, 2022 | August 23, 2022 | August 31, 2022 | $ | 0.25 | $24.7 million | (1) | |||||||||||||
Fiscal Quarter Ended July 1, 2022 | Fiscal Year-To-Date Ended July 1, 2022 | ||||||||||||||||||||||||||||
Investment Securities | Cash Flow Hedges | Currency Translation Adjustments | Total | Investment Securities | Cash Flow Hedges | Currency Translation Adjustments | Total | ||||||||||||||||||||||
Beginning Balance | $ | (3,800) | $ | 56 | $ | (11,937) | $ | (15,681) | $ | 220 | $ | (122) | $ | (10,128) | $ | (10,030) | |||||||||||||
Other comprehensive loss before reclassifications: | |||||||||||||||||||||||||||||
Unrealized losses | (414) | (362) | — | (776) | (4,971) | (6) | — | (4,977) | |||||||||||||||||||||
Foreign currency translation losses (1) | — | — | (13,821) | (13,821) | — | — | (15,630) | (15,630) | |||||||||||||||||||||
Income tax effect - benefit | — | 97 | — | 97 | — | — | — | — | |||||||||||||||||||||
Net of tax | (414) | (265) | (13,821) | (14,500) | (4,971) | (6) | (15,630) | (20,607) | |||||||||||||||||||||
Amounts reclassified from AOCI into earnings: | |||||||||||||||||||||||||||||
Realized gains/(losses) (2) | (15) | (314) | — | (329) | 527 | (412) | — | 115 | |||||||||||||||||||||
Income tax effect - benefit/(expense) (3) | 3 | 81 | — | 84 | (2) | 98 | — | 96 | |||||||||||||||||||||
Net of tax | (12) | (233) | — | (245) | 525 | (314) | — | 211 | |||||||||||||||||||||
Net current-period other comprehensive loss | (426) | (498) | (13,821) | (14,745) | (4,446) | (320) | (15,630) | (20,396) | |||||||||||||||||||||
Ending Balance | $ | (4,226) | $ | (442) | $ | (25,758) | $ | (30,426) | $ | (4,226) | $ | (442) | $ | (25,758) | $ | (30,426) |
Fiscal Quarter Ended June 25, 2021 | Fiscal Year-To-Date Ended June 25, 2021 | ||||||||||||||||||||||||||||
Investment Securities | Cash Flow Hedges | Currency Translation Adjustments | Total | Investment Securities | Cash Flow Hedges | Currency Translation Adjustments | Total | ||||||||||||||||||||||
Beginning Balance | $ | 458 | $ | 3,751 | $ | (8,248) | $ | (4,039) | $ | 818 | $ | 3,969 | $ | (15,381) | $ | (10,594) | |||||||||||||
Other comprehensive income/(loss) before reclassifications: | |||||||||||||||||||||||||||||
Unrealized losses | (212) | (4,293) | — | (4,505) | (819) | (8,203) | — | (9,022) | |||||||||||||||||||||
Foreign currency translation gains | — | — | 937 | 937 | — | — | 8,577 | 8,577 | |||||||||||||||||||||
Income tax effect - benefit/(expense) | 44 | 115 | (110) | 49 | 100 | 180 | (617) | (337) | |||||||||||||||||||||
Net of tax | (168) | (4,178) | 827 | (3,519) | (719) | (8,023) | 7,960 | (782) | |||||||||||||||||||||
Amounts reclassified from AOCI into earnings: | |||||||||||||||||||||||||||||
Realized gains (2) | 8 | 2,758 | — | 2,766 | 209 | 6,780 | — | 6,989 | |||||||||||||||||||||
Income tax effect - expense (3) | (2) | (238) | — | (240) | (12) | (633) | — | (645) | |||||||||||||||||||||
Net of tax | 6 | 2,520 | — | 2,526 | 197 | 6,147 | — | 6,344 | |||||||||||||||||||||
Net current-period other comprehensive income/(loss) | (162) | (1,658) | 827 | (993) | (522) | (1,876) | 7,960 | 5,562 | |||||||||||||||||||||
Ending Balance | $ | 296 | $ | 2,093 | $ | (7,421) | $ | (5,032) | $ | 296 | $ | 2,093 | $ | (7,421) | $ | (5,032) |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||
July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | ||||||||||||||
Numerator: | |||||||||||||||||
Net income attributable to Dolby Laboratories, Inc. | $ | 39,597 | $ | 54,621 | $ | 156,331 | $ | 266,036 | |||||||||
Denominator: | |||||||||||||||||
Weighted-average shares outstanding—basic | 100,213 | 101,351 | 100,936 | 101,177 | |||||||||||||
Potential common shares from options to purchase common stock | 779 | 2,062 | 1,037 | 2,033 | |||||||||||||
Potential common shares from restricted stock units | 409 | 1,169 | 916 | 1,319 | |||||||||||||
Potential common shares from employee stock purchase plan | 73 | 51 | 104 | 78 | |||||||||||||
Weighted-average shares outstanding—diluted | 101,474 | 104,633 | 102,993 | 104,607 | |||||||||||||
Net income per share attributable to Dolby Laboratories, Inc.: | |||||||||||||||||
Basic | $ | 0.40 | $ | 0.54 | $ | 1.55 | $ | 2.63 | |||||||||
Diluted | $ | 0.39 | $ | 0.52 | $ | 1.52 | $ | 2.54 | |||||||||
Antidilutive awards excluded from calculation: | |||||||||||||||||
Stock options | 756 | 283 | 552 | 200 | |||||||||||||
Restricted stock units | 2,304 | — | 1,088 | 12 | |||||||||||||
Employee stock purchase plan | — | 1 | — | 2 |
Severance | Leased facility exit costs and other costs | Total | |||||||||
Balance at September 25, 2020 | $ | — | $ | — | $ | — | |||||
Restructuring charges | 9,522 | 718 | 10,240 | ||||||||
Cash payments and adjustments | (9,359) | (714) | (10,073) | ||||||||
Balance at September 24, 2021 | $ | 163 | $ | 4 | $ | 167 | |||||
Restructuring charges | 4,336 | 1,707 | 6,043 | ||||||||
Cash payments and adjustments | (3,256) | (1,711) | (4,967) | ||||||||
Balance at July 1, 2022 | $ | 1,243 | $ | — | $ | 1,243 | |||||
Payments Due By Fiscal Period | |||||||||||||||||||||||
Remainder of Fiscal 2022 | Fiscal 2023 | Fiscal 2024 | Fiscal 2025 | Fiscal 2026 | Thereafter | Total | |||||||||||||||||
Naming rights | $ | 2,075 | $ | 12,474 | $ | 12,794 | $ | 13,126 | $ | 13,472 | $ | 52,850 | $ | 106,791 | |||||||||
Purchase obligations | 8,649 | 27,455 | 4,809 | 512 | — | — | 41,425 | ||||||||||||||||
Donation commitments | 1,651 | 196 | 116 | 116 | 116 | 503 | 2,698 | ||||||||||||||||
Total | $ | 12,375 | $ | 40,125 | $ | 17,719 | $ | 13,754 | $ | 13,588 | $ | 53,353 | $ | 150,914 |
Technology | Description | ||||
AAC & HE-AAC | An advanced digital audio codec solution with higher bandwidth efficiency used for a wide range of media applications. | ||||
AVC | A digital video codec with high bandwidth efficiency used in a wide range of media devices. | ||||
Dolby® AC-4 | A next-generation digital audio coding technology that increases transmission efficiency while delivering new audio experiences, including Dolby Atmos, to a wide range of playback devices. | ||||
Dolby Atmos® | An object-oriented audio technology for cinema and a wide range of media devices that allows sound to be precisely placed and moved anywhere in the listening environment including the overhead dimension. Dolby Atmos provides an immersive experience that can be provided via multiple Dolby audio coding technologies. | ||||
Dolby Digital® | A digital audio coding technology that provides multichannel sound to a variety of media applications. | ||||
Dolby Digital Plus™ | An advanced digital audio coding technology that offers more efficient audio transmission for a wide range of media applications and devices. | ||||
Dolby® TrueHD | A digital audio coding technology providing lossless encoding for premium quality media applications. | ||||
Dolby Vision® | An imaging technology combining high dynamic range and dynamic metadata to deliver ultra vivid colors, sharper contrasts, and richer details for cinema and a wide range of media devices. | ||||
Dolby Voice® | An audio communications technology with superior spatial perception, voice clarity, and background noise reduction that emulates the in-person meeting experience. | ||||
HEVC | A digital video codec with high bandwidth efficiency to support ultra-high definition experiences for a wide range of media devices. |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | |||||||||||||||||||
Market | July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | Main Offerings Incorporating Our Technologies | |||||||||||||||
Broadcast | 37% | 46% | 36% | 39% | Televisions and STBs | |||||||||||||||
Mobile | 23% | 18% | 22% | 23% | Smartphones and Tablets | |||||||||||||||
CE | 14% | 14% | 16% | 15% | DMAs, Blu-ray Disc devices, AVRs, Soundbars, and DVDs | |||||||||||||||
PC | 10% | 9% | 13% | 11% | Windows and macOS operating systems | |||||||||||||||
Other | 16% | 13% | 13% | 12% | Gaming consoles, Auto DVD, and Dolby Cinema | |||||||||||||||
Total | 100% | 100% | 100% | 100% |
Product | Description | |||||||
Cinema | Cinema Imaging Products | Digital Cinema Servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode, and package digital media files for distribution | ||||||
Cinema Audio Products | Cinema Processors, amplifiers, and loudspeakers used to decode, render, and optimally playback digital cinema soundtracks, including those using Dolby Atmos | |||||||
Other | Other Products | 3-D glasses and kits, broadcast hardware and software used to encode, transmit, and decode multiple channels of high-quality audio for DTV and HDTV distribution, monitors, accessibility solutions for hearing and visually impaired consumers, and Dolby.io |
Fiscal Quarter Ended | Change | Fiscal Year-To-Date Ended | Change | ||||||||||||||||||||||||||
Licensing | July 1, 2022 | June 25, 2021 | $ | % | July 1, 2022 | June 25, 2021 | $ | % | |||||||||||||||||||||
Revenue | $269,289 | $271,569 | $(2,280) | (1)% | $915,406 | $948,159 | $(32,753) | (3)% | |||||||||||||||||||||
Percentage of total revenue | 93% | 95% | 94% | 95% | |||||||||||||||||||||||||
Cost of licensing | 13,756 | 12,480 | 1,276 | 10% | 45,363 | 41,486 | 3,877 | 9% | |||||||||||||||||||||
Gross margin | 255,533 | 259,089 | (3,556) | (1)% | 870,043 | 906,673 | (36,630) | (4)% | |||||||||||||||||||||
Gross margin percentage | 95% | 95% | 95% | 96% |
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||||||||||||||||||||
Licensing Revenue By Market | July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | |||||||||||||||||||||||||||||||
Broadcast | $ | 99,327 | 37 | % | $ | 123,955 | 46 | % | $ | 325,441 | 36 | % | $ | 368,068 | 39 | % | |||||||||||||||||||
Mobile | 63,237 | 23 | % | 49,861 | 18 | % | 204,212 | 22 | % | 221,157 | 23 | % | |||||||||||||||||||||||
CE | 38,663 | 14 | % | 37,805 | 14 | % | 150,192 | 16 | % | 138,010 | 15 | % | |||||||||||||||||||||||
PC | 26,947 | 10 | % | 24,870 | 9 | % | 119,190 | 13 | % | 108,709 | 11 | % | |||||||||||||||||||||||
Other | 41,115 | 16 | % | 35,078 | 13 | % | 116,371 | 13 | % | 112,215 | 12 | % | |||||||||||||||||||||||
Total licensing revenue | $ | 269,289 | 100 | % | $ | 271,569 | 100 | % | $ | 915,406 | 100 | % | $ | 948,159 | 100 | % |
Factor | Licensing Revenue | Gross Margin | ||||||||||||
Broadcast | â | Lower foundational audio revenue due to higher recoveries and a true-up in the prior year, and lower estimated units of TVs and STBs, partially offset by higher adoption of Dolby Vision and Dolby Atmos technologies and new licensees in our imaging patent programs | ßà | No significant fluctuations | ||||||||||
Mobile | á | Higher revenue due to timing of revenue under contract for Dolby Atmos and audio patent licensing technologies, and higher adoption of Dolby Vision and Dolby Atmos | ||||||||||||
Other | á | Higher revenue from Dolby Cinema due to strong box office performance from highly anticipated theatrical title releases | ||||||||||||
PC | á | Higher revenue due to higher foundational audio revenue due to higher recoveries and higher adoption of our Dolby Atmos and Dolby Vision technologies, partially offset by lower units | ||||||||||||
CE | á | Higher revenue due to higher adoption of Dolby Atmos and Dolby Vision in DMAs and soundbars | ||||||||||||
Factor | Licensing Revenue | Gross Margin | ||||||||||||
Broadcast | â | Lower foundational audio revenue for TVs due to a true-up in the prior year, lower TV units, and lower recoveries | ßà | No significant fluctuations | ||||||||||
Mobile | â | Lower revenue from lower recoveries and from our audio patent licensing technologies, partially offset by higher revenue due to new licensees in our imaging patent programs | ||||||||||||
CE | á | Higher revenue due to higher adoption of Dolby Atmos and Dolby Vision across devices, new licensees in our imaging patent programs, and higher recoveries, partially offset by lower revenue from our audio patent licensing technologies | ||||||||||||
PC | á | Higher revenue from recoveries, higher adoption of Dolby Vision and Dolby Atmos technologies and new licensees in our imaging patent programs, partially offset by lower foundational audio revenue due to timing of contracts | ||||||||||||
Other | á | Higher Dolby Cinema revenue due to more screens being open and strong box office performance in fiscal 2022, partially offset by lower gaming revenue due to ongoing supply constraints and lower automotive revenue | ||||||||||||
Fiscal Quarter Ended | Change | Fiscal Year-To-Date Ended | Change | ||||||||||||||||||||||||||
Products and Services | July 1, 2022 | June 25, 2021 | $ | % | July 1, 2022 | June 25, 2021 | $ | % | |||||||||||||||||||||
Revenue | $20,296 | $15,230 | $5,066 | 33% | $60,183 | $48,072 | $12,111 | 25% | |||||||||||||||||||||
Percentage of total revenue | 7% | 5% | 6% | 5% | |||||||||||||||||||||||||
Cost of products and services | 22,201 | 19,164 | 3,037 | 16% | 58,818 | 57,840 | 978 | 2% | |||||||||||||||||||||
Gross margin | (1,905) | (3,934) | 2,029 | (52)% | 1,365 | (9,768) | 11,133 | (114)% | |||||||||||||||||||||
Gross margin percentage | (9)% | (26)% | 2% | (20)% |
Factor | Products and Services Revenue | Gross Margin | ||||||||||||
Products | á | Higher sales of cinema equipment attributable to increased demand as the exhibitor market continues to recover | á | Higher gross margin due to higher cinema products revenue | ||||||||||
Services | ßà | No significant fluctuations | â | Lower gross margin due to increased warranty expense on Dolby Cinema equipment |
Factor | Products and Services Revenue | Gross Margin | ||||||||||||
Products | á | Higher sales of cinema equipment attributable to increased demand as the exhibitor market continues to recover | á | Higher sales of cinema equipment attributable to increased demand, lower scrap in the current year, and higher absorption of manufacturing overhead, offset by higher COGS due to higher prices of components | ||||||||||
Services | á | Higher services revenue from Broadcast licensing services and our developer platform, offset by lower sales of Dolby Voice as a result of winding down that business | â | Lower gross margin due to increased warranty expense on Dolby Cinema equipment, offset by higher revenue |
Fiscal Quarter Ended | Change | Fiscal Year-To-Date Ended | Change | ||||||||||||||||||||||||||
July 1, 2022 | June 25, 2021 | $ | % | July 1, 2022 | June 25, 2021 | $ | % | ||||||||||||||||||||||
Research and development | $62,859 | $62,094 | $765 | 1% | $199,104 | $191,674 | $7,430 | 4% | |||||||||||||||||||||
Percentage of total revenue | 22% | 22% | 20% | 19% |
Category | Key Drivers | |||||||
Stock-based Compensation | á | Higher costs of $1.9 million primarily due to increased fair value of RSUs | ||||||
Compensation & Benefits | â | Lower costs of $1.6 million primarily due to our annual bonus program | ||||||
Category | Key Drivers | |||||||
Stock-based Compensation | á | Higher costs of $6.0 million primarily due to increased fair value of RSUs | ||||||
Compensation & Benefits | â | Lower costs of $8.0 million primarily due to our annual bonus program, partially offset by higher salaries expense of $2.2 million primarily due to severance payments and other costs from the reorganization of our entertainment organization, and the extra week in the first quarter of fiscal 2022 | ||||||
Fiscal Quarter Ended | Change | Fiscal Year-To-Date Ended | Change | ||||||||||||||||||||||||||
July 1, 2022 | June 25, 2021 | $ | % | July 1, 2022 | June 25, 2021 | $ | % | ||||||||||||||||||||||
Sales and marketing | $87,114 | $80,714 | $6,400 | 8% | $268,514 | $234,205 | $34,309 | 15% | |||||||||||||||||||||
Percentage of total revenue | 30% | 28% | 28% | 24% |
Category | Key Drivers | |||||||
Travel | á | Higher costs of $1.6 million for company travel and trade shows due to COVID-19 travel restrictions in the prior year | ||||||
Compensation & Benefits | á | Higher costs of $1.7 million due to higher salaries expense due to increased headcount, partially offset due to lower costs of $1.4 million due to incentive compensation | ||||||
Category | Key Drivers | |||||||
Marketing Programs | á | Higher costs of $12.0 million primarily due to marketing efforts for growth initiatives and branding activities | ||||||
Legal, Professional, & Consulting | á | Higher costs of $9.8 million primarily due to legal support for licensee audits and higher consulting expense for the increased development of digital marketing programs | ||||||
Stock-based Compensation | á | Higher costs of $3.6 million primarily due to increased fair value of RSUs | ||||||
Compensation & Benefits | á | Higher costs of $7.3 million for higher salaries expense primarily due to increased headcount and the extra week in the current fiscal year, partially offset by lower costs of $7.1 million primarily due to lower incentive compensation | ||||||
Fiscal Quarter Ended | Change | Fiscal Year-To-Date Ended | Change | ||||||||||||||||||||||||||
July 1, 2022 | June 25, 2021 | $ | % | July 1, 2022 | June 25, 2021 | $ | % | ||||||||||||||||||||||
General and administrative | $57,113 | $56,116 | $997 | 2% | $218,250 | $169,968 | $48,282 | 28% | |||||||||||||||||||||
Percentage of total revenue | 20% | 20% | 22% | 17% |
Category | Key Drivers | |||||||
General and administrative | ßà | No significant fluctuations | ||||||
Category | Key Drivers | |||||||
Other Miscellaneous Expenses | á | Higher costs of $34.4 million related to the resolution of a legal matter discussed in Note 15 to the condensed consolidated financial statements | ||||||
Compensation & Benefits | á | Higher costs of $5.3 million for higher salaries expense primarily due to increased headcount and the extra week in the current fiscal year, offset by lower costs of $5.2 million primarily due to our annual bonus program | ||||||
Fiscal Year-To-Date Ended | Change | |||||||||||||
July 1, 2022 | June 25, 2021 | $ | % | |||||||||||
Gain on sale of assets | $— | $(13,871) | $13,871 | (100)% | ||||||||||
Percentage of total revenue | —% | (1)% |
Fiscal Quarter Ended | Change | Fiscal Year-To-Date Ended | Change | ||||||||||||||||||||||||||
July 1, 2022 | June 25, 2021 | $ | % | July 1, 2022 | June 25, 2021 | $ | % | ||||||||||||||||||||||
Restructuring charges | $976 | $140 | $836 | 597% | $6,043 | $10,904 | $(4,861) | (45)% | |||||||||||||||||||||
Percentage of total revenue | —% | —% | 1% | 1% |
Fiscal Quarter Ended | Change | Fiscal Year-To-Date Ended | Change | ||||||||||||||||||||||||||
July 1, 2022 | June 25, 2021 | $ | % | July 1, 2022 | June 25, 2021 | $ | % | ||||||||||||||||||||||
Other income | $3,846 | $3,034 | $812 | 27% | $4,808 | $7,429 | $(2,621) | (35)% | |||||||||||||||||||||
Percentage of total revenue | 1% | 1% | —% | 1% |
Category | Key Drivers | |||||||
Other Income | ßà | No significant fluctuations | ||||||
Category | Key Drivers | |||||||
Other Income | â | Lower income primarily due to lower yields on our SERP balances in the current year | ||||||
Fiscal Quarter Ended | Fiscal Year-To-Date Ended | ||||||||||||||||
July 1, 2022 | June 25, 2021 | July 1, 2022 | June 25, 2021 | ||||||||||||||
Provision for income taxes | $(9,802) | $(4,565) | $(28,166) | $(37,859) | |||||||||||||
Effective tax rate | 19.8% | 7.7% | 15.3% | 12.2% |
Factor | Impact On Effective Tax Rate | |||||||
Stock-based Compensation | á | Lower benefit related to the settlement of stock-based awards. | ||||||
Foreign Operations | á | Lower benefit from earned income in lower tax jurisdictions. | ||||||
Tax Contingencies | â | Higher benefit from the settlement of Federal tax audit | ||||||
Factor | Impact On Effective Tax Rate | |||||||
Stock-based Compensation | á | Lower benefit related to the settlement of stock-based awards | ||||||
Foreign Operations | á | Lower benefit from earned income in lower tax jurisdictions. | ||||||
Fiscal Quarter Ended | Change | Fiscal Year-To-Date Ended | Change | ||||||||||||||||||||||||||
July 1, 2022 | June 25, 2021 | $ | % | July 1, 2022 | June 25, 2021 | $ | % | ||||||||||||||||||||||
Net (income)/loss attributable to controlling interest | $(13) | $61 | $(74) | (121)% | $192 | $(7,559) | $7,751 | (103)% | |||||||||||||||||||||
Percentage of total revenue | —% | —% | —% | (1)% |
July 1, 2022 | September 24, 2021 | ||||||||||
Cash and cash equivalents | $ | 858,905 | $ | 1,225,380 | |||||||
Short-term investments | 156,812 | 38,839 | |||||||||
Long-term investments | 106,726 | 62,819 | |||||||||
Accounts receivable, net | 236,229 | 232,609 | |||||||||
Accounts payable and accrued liabilities | 246,088 | 280,507 | |||||||||
Working capital | 1,219,234 | 1,444,781 | |||||||||
Fiscal Year-to-Date Ended | |||||||||||
July 1, 2022 | June 25, 2021 | ||||||||||
Net cash provided by operating activities | $ | 267,267 | $ | 337,980 |
Factor | Impact On Cash Flows | |||||||
Net Income | â | Lower revenue, higher S&M expenses, and higher costs associated with the resolution of a legal matter discussed in Note 15 to the condensed consolidated financial statements, offset by a decrease in accounts receivable | ||||||
Fiscal Year-to-Date Ended | |||||||||||
July 1, 2022 | June 25, 2021 | ||||||||||
Net cash used in investing activities | $ | (255,213) | $ | (29,948) | |||||||
Factor | Impact On Cash Flows | |||||||
Purchase of Investments | â | Higher outflows for the purchase of marketable investment securities, and other investments | ||||||
Proceeds from Investments | á | Higher inflows from the sale and maturity of marketable investment securities | ||||||
Business Combinations | â | Higher outflows for the acquisition of Millicast completed in fiscal 2022 | ||||||
Sale of Assets | â | Lower inflows for the sale of property in the prior year that was 51% owned by the controlling interest | ||||||
Fiscal Year-to-Date Ended | |||||||||||
July 1, 2022 | June 25, 2021 | ||||||||||
Net cash used in financing activities | $ | (368,131) | $ | (165,650) | |||||||
Factor | Impact On Cash Flows | |||||||
Share Repurchases | â | Higher outflows from increases in common stock repurchases | ||||||
Common Stock Issuance | â | Lower inflows from employee stock option exercises | ||||||
Dividend Payments | â | Higher outflows for the payment of our quarterly cash dividend to common stockholders primarily as a result of a $0.03 per share increase compared to the prior fiscal year | ||||||
Distribution to Controlling Interest | á | Lower outflows for distributions to controlling interest due to the sale of property that was 51% owned by the controlling interest in fiscal 2021, that did not recur in fiscal 2022 | ||||||
Repurchase Activity | Total Shares Repurchased | Average Price Paid Per Share (1) | Total Shares Purchased As Part Of Publicly Announced Programs | Remaining Authorized Share Repurchases (2) | ||||||||||
April 2, 2022 - April 29, 2022 | — | $— | — | $420.9 million | ||||||||||
April 30, 2022 - May 27, 2022 | 1,071,950 | $74.73 | 1,071,950 | $340.7 million | ||||||||||
May 28, 2022 - July 1, 2022 | 1,477,524 | $74.38 | 1,477,524 | $230.9 million | ||||||||||
Total | 2,549,474 | 2,549,474 |
Exhibit Number | Description | Incorporated By Reference Herein | ||||||||||||||||||||||||||||||
Form | File Number | Date | Provided Herewith | |||||||||||||||||||||||||||||
10.1* | X | |||||||||||||||||||||||||||||||
31.1 | X | |||||||||||||||||||||||||||||||
31.2 | X | |||||||||||||||||||||||||||||||
32.1+ | X | |||||||||||||||||||||||||||||||
101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X | ||||||||||||||||||||||||||||||
101.SCH | XBRL Taxonomy Extension Schema Document | X | ||||||||||||||||||||||||||||||
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||||||||||||||||||||||
101.DEF | XBRL Extension Definition | X | ||||||||||||||||||||||||||||||
101.LAB | XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||||||||||||||||||||||
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||||||||||||||||||||||||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | X |
DOLBY LABORATORIES, INC. | |||||
By: | /S/ ROBERT PARK | ||||
Robert Park | |||||
Senior Vice President and Chief Financial Officer | |||||
(Principal Financial Officer) | |||||
/s/ KEVIN J. YEAMAN | ||
Kevin J. Yeaman | ||
President and Chief Executive Officer (Principal Executive Officer) |
/s/ ROBERT PARK | ||
Robert Park | ||
Senior Vice President and Chief Financial Officer (Principal Financial Officer) |
/s/ KEVIN J. YEAMAN | ||
Kevin J. Yeaman President and Chief Executive Officer (Principal Executive Officer) | ||
/s/ ROBERT PARK | ||
Robert Park Senior Vice President and Chief Financial Officer (Principal Financial Officer) |